Lawrence O. Klein
Overview
Lawrence O. Klein received an average of $5M in total compensation, including $410K in salary, at CRISPR Therapeutics AG from 2019 to 2021.
Source: SEC filings on April 25, 2022, April 28, 2021, and April 24, 2020.
Related executives
We found eight more executives who work or worked at CRISPR Therapeutics AG.
Samarth Kulkarni
CRISPR Therapeutics AG
Chief Executive Officer
Brendan Smith
CRISPR Therapeutics AG
Chief Financial Officer
Tony Ho
CRISPR Therapeutics AG
Former EVP, Research and Development
James Kasinger
CRISPR Therapeutics AG
General Counsel
Michael Tomsicek
CRISPR Therapeutics AG
Chief Financial Officer
Rodger Novak
CRISPR Therapeutics AG
President
Marc Becker
CRISPR Therapeutics AG
Chief Financial Officer
Kala Subramanian
CRISPR Therapeutics AG